HomeRGNX • NASDAQ
add
Regenxbio Inc
Previous close
$8.64
Day range
$8.42 - $9.09
Year range
$5.04 - $16.25
Market cap
445.93M USD
Avg Volume
1.20M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 89.01M | 469.79% |
Operating expense | 20.36M | 11.53% |
Net income | 6.08M | 109.61% |
Net profit margin | 6.83 | 101.68% |
Earnings per share | 0.12 | 108.96% |
EBITDA | 16.08M | 127.93% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 267.87M | -20.91% |
Total assets | 490.93M | -21.98% |
Total liabilities | 216.73M | -9.15% |
Total equity | 274.20M | — |
Shares outstanding | 50.16M | — |
Price to book | 1.58 | — |
Return on assets | 6.34% | — |
Return on capital | 7.49% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 6.08M | 109.61% |
Cash from operations | 33.63M | 160.64% |
Cash from investing | 44.74M | 239.40% |
Cash from financing | -5.79M | -104.80% |
Net change in cash | 72.58M | -7.49% |
Free cash flow | 6.88M | 121.68% |
About
Founded
2008
Headquarters
Website
Employees
353
